Jude Samulski, PhD, Professor of Pharmacology and the UNC Gene Therapy Center is profiled by Endpoints News in: From bench to boardroom: 20 of the most influential biopharma R&D executives in drug development.
In their profile they note “we polled industry executives on who they viewed as the R&D luminaries of note — men and women across the drug development spectrum who take major biological and chemical breakthroughs and spin them like gold into medical miracles. These are the people who opened doors to new fields of drug research, laying the foundation for much of the work now underway in the clinic.”
Samulski is in good company, joining the likes of David Altshuler, Patrick Baeuerle, Jay Bradner, David Chang, Stanley Crooke, Frank Fan, Carole Ho, Kathrin Jansen, Katalin Karikó, Cynthia Kenyon, John Leonard, John Maraganore, Frank McCormick, Richard Mulligan, Roger Perlmutter, Aviv Regev, Richard Scheller, David Schenkein, and George Yancopoulos.
Our congratulations to Dr. Samulski!